Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Nicolas Wisniacki | Researchclopedia

Back to researchers

Nicolas Wisniacki

GlaxoSmithKline (United Kingdom)ORCID

21

Works

620

Citations

13

h-index

14

i10-index

Research Topics

Systemic Sclerosis and Related Diseases Salivary Gland Disorders and Functions T-cell and B-cell Immunology

Affiliations

Biogen (United States)2014–2014

GlaxoSmithKline (United Kingdom)2017–2025

Age UK2018–2025

North Hertfordshire College2022–2022

Biogen (United Kingdom)2012–2016

Top Works

Role of TWEAK in lupus nephritis: A bench-to-bedside review

Jennifer S. Michaelson,Nicolas Wisniacki,et al.

2012117 citations

Systemic Lupus Erythematosus Research

Salivary Gland Tumors Diagnosis and Treatment

A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome

Xavier Mariette,Francesca Barone,et al.

2022113 citations

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-TWEAK Monoclonal Antibody in Patients With Rheumatoid Arthritis

Nicolas Wisniacki,Lakshmi Amaravadi,et al.

201370 citations

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes

Bart Keymeulen,André van Maurik,et al.

202047 citations

<i>In vivo</i> affinity and target engagement in skin and blood in a first‐time‐in‐human study of an anti‐oncostatin M monoclonal antibody

Juliet Reid,Stefano Zamuner,et al.

201846 citations

The role of the oncostatin M/OSM receptor β axis in activating dermal microvascular endothelial cells in systemic sclerosis

Grace Marden,Qi Wan,et al.

202036 citations

Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis

Christopher P. Denton,Francesco Del Galdo,et al.

202232 citations

Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis

Kristina E N Clark,Corrado Campochiaro,et al.

202132 citations

Depletion of LAG‐3<sup>+</sup> T Cells Translated to Pharmacology and Improvement in Psoriasis Disease Activity: A Phase I Randomized Study of mAb GSK2831781

Joanne Ellis,Daniel JB Marks,et al.

202032 citations